Collegium Pharmaceutical Stock Options
| COLL Stock | USD 29.79 0.36 1.19% |
Collegium Pharmaceutical's latest option contracts expiring on June 20th 2025 are carrying combined implied volatility of 0.7 with a put-to-call open interest ratio of 0.56 over 20 outstanding agreements suggesting investors are buying more calls than puts on contracts expiring on June 20th 2025.
Open Interest Against June 20th 2025 Option Contracts
2025-06-20
The chart above shows Collegium Pharmaceutical's distribution of open interest by maturity on contracts that have not yet been settled. The area between the two highest points is the projection of the price at expiration. Collegium Pharmaceutical's open interest chart also provides vital information regarding the liquidity of an option. If there is no open interest for Collegium Pharmaceutical's option, there is no secondary market available for investors to trade.
In The Money vs. Out of Money Option Contracts on Collegium Pharmaceutical
Analyzing Collegium Pharmaceutical's in-the-money options over time can help investors to take a profitable long position in Collegium Pharmaceutical regardless of its overall volatility. This is especially true when Collegium Pharmaceutical's options are deep in the money. These options can be identified using deltas that are over 0.75. Deep in-the-money Collegium Pharmaceutical's options could be used as guardians of the underlying stock as they move almost dollar for dollar with Collegium Pharmaceutical's stock while costing only a fraction of its price.
Collegium Pharmaceutical In The Money Call Balance
When Collegium Pharmaceutical's strike price is surpassing the current stock price, the option contract against Collegium Pharmaceutical stock is said to be in the money. When it comes to buying Collegium Pharmaceutical's options that are 'In the Money' or 'Out of the Money', the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
While 'out-of-the-money' option contracts written on Collegium Pharmaceutical are typically viewed as the more aggressive, there are potential upsides to purchasing these types of options contracts. For one, the cost to buy an 'Out of the Money' option is lower than the cost to buy an 'In the Money' option. This cost-benefit is due to the fact that at the time of the purchase, 'Out of the Money' contracts have no intrinsic value. So, while the potential for a 100% loss is more significant, the cost and risk to enter the trade are lower.
Collegium Current Options Market Mood
Collegium Pharmaceutical's open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Collegium Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.
Put-to-Call Open Interest
Put-to-Call Volume
Unfortunately, most Collegium Pharmaceutical's options investors are not very successful. Collegium Pharmaceutical's option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction.
Rule 16 of the current Collegium contract
Base on the Rule 16, the options market is currently suggesting that Collegium Pharmaceutical will have an average daily up or down price movement of about 0.0438% per day over the life of the 2025-06-20 option contract. With Collegium Pharmaceutical trading at USD 29.79, that is roughly USD 0.013. If you think that the market is fully incorporating Collegium Pharmaceutical's daily price movement you should consider buying Collegium Pharmaceutical options at the current volatility level of 0.7%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Collegium |
Purchasing Collegium Pharmaceutical options can give investors a meaningful hedge against losses and, therefore, could be used conservatively to decrease the volatility of your portfolio. However, many options could also amount to little more than gambling, significantly enhancing your overall portfolio risk. One simple example of these aggressive strategies is the sale of "uncovered" Collegium calls. Remember, the seller must deliver Collegium Pharmaceutical stock to the call owner when a call is exercised.
Collegium Pharmaceutical Option Chain
When Collegium Pharmaceutical's strike price is surpassing the current stock price, the option contract against Collegium Pharmaceutical stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
Collegium Pharmaceutical's option chain is a display of a range of information that helps investors for ways to trade options on Collegium. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Collegium. It also shows strike prices and maturity days for a Collegium Pharmaceutical against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone. | Open Int | Strike Price | Current Spread | Last Price | |||
Call | COLL250620C00055000 | 21 | 55.0 | 0.0 - 2.15 | 1.35 | Out |
Call | COLL250620C00050000 | 12 | 50.0 | 0.0 - 2.15 | 0.8 | Out |
Call | COLL250620C00045000 | 13 | 45.0 | 0.0 - 2.25 | 1.1 | Out |
Call | COLL250620C00040000 | 11 | 40.0 | 0.0 - 2.55 | 1.2 | Out |
Call | COLL250620C00035000 | 4 | 35.0 | 0.0 - 2.5 | 1.75 | Out |
Call | COLL250620C00030000 | 16 | 30.0 | 1.05 - 5.0 | 2.65 | Out |
Call | COLL250620C00025000 | 2 | 25.0 | 4.3 - 8.3 | 6.04 | In |
Call | COLL250620C00022500 | 0 | 22.5 | 6.4 - 10.3 | 6.4 | In |
Call | COLL250620C00020000 | 0 | 20.0 | 8.6 - 12.6 | 8.6 | In |
Call | COLL250620C00017500 | 0 | 17.5 | 11.1 - 14.9 | 11.1 | In |
Put | COLL250620P00055000 | 1 | 55.0 | 22.9 - 26.9 | 19.9 | In |
Put | COLL250620P00050000 | 3 | 50.0 | 17.8 - 21.8 | 18.7 | In |
Put | COLL250620P00045000 | 12 | 45.0 | 13.0 - 16.8 | 14.8 | In |
Put | COLL250620P00040000 | 18 | 40.0 | 8.0 - 11.8 | 9.9 | In |
Put | COLL250620P00035000 | 0 | 35.0 | 3.7 - 7.5 | 3.7 | In |
Put | COLL250620P00030000 | 1 | 30.0 | 0.55 - 4.6 | 3.9 | Out |
Put | COLL250620P00025000 | 2 | 25.0 | 0.0 - 2.9 | 1.53 | Out |
Put | COLL250620P00022500 | 3 | 22.5 | 0.0 - 2.5 | 1.7 | Out |
Put | COLL250620P00020000 | 3 | 20.0 | 0.0 - 2.25 | 1.65 | Out |
Put | COLL250620P00017500 | 1 | 17.5 | 0.0 - 2.15 | 1.0 | Out |
Collegium Pharmaceutical Selling And Marketing Expenses Over Time
Selling And Marketing Expenses |
| Timeline |
Collegium Pharmaceutical Market Cap Over Time
Market Cap |
| Timeline |
Collegium Total Stockholder Equity
Total Stockholder Equity |
|
Collegium Pharmaceutical Corporate Management
| Shirley JD | General VP | Profile | |
| Bart Dunn | Executive Development | Profile | |
| Scott Sudduth | Head Operations | Profile | |
| Christopher MD | Vice Relations | Profile | |
| Marlo Manning | Head HR | Profile |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Collegium Pharmaceutical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. For more information on how to buy Collegium Stock please use our How to buy in Collegium Stock guide.You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Collegium Pharmaceutical. If investors know Collegium will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Collegium Pharmaceutical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.62) | Earnings Share 1.86 | Revenue Per Share | Quarterly Revenue Growth 0.215 | Return On Assets |
The market value of Collegium Pharmaceutical is measured differently than its book value, which is the value of Collegium that is recorded on the company's balance sheet. Investors also form their own opinion of Collegium Pharmaceutical's value that differs from its market value or its book value, called intrinsic value, which is Collegium Pharmaceutical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Collegium Pharmaceutical's market value can be influenced by many factors that don't directly affect Collegium Pharmaceutical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Collegium Pharmaceutical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Collegium Pharmaceutical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Collegium Pharmaceutical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.